Sign up to save your podcasts
Or
Share Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
View all episodes
By JAMA Network
4.3
105105 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
More shows like Coronavirus (COVID-19) Q&A
View all
JAMA Clinical Reviews
488 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Cardiology Author Interviews
9 Listeners
JAMA Dermatology Author Interviews
17 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Oncology Author Interviews
12 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
6 Listeners
JAMA Pediatrics Author Interviews
8 Listeners
JAMA Psychiatry Author Interviews
23 Listeners
JAMA Medical News
89 Listeners
JAMAevidence Care at the Close of Life
5 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
JAMAevidence Users' Guides to the Medical Literature
14 Listeners
JAMA Network Open Conversations
5 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
17 Listeners
JAMA Health Forum Conversations
2 Listeners
JAMA Author Interviews
163 Listeners